Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Evotec stock

Learn how to easily invest in Evotec stock.

Evotec SE ADR is a drug manufacturers-specialty & generic business based in the US. Evotec shares (EVO) are listed on the NASDAQ and all prices are listed in US Dollars. Evotec employs 4,521 staff and has a trailing 12-month revenue of around $683.6 million.

How to buy shares in Evotec

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EVO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Evotec stock price (NASDAQ: EVO)

Use our graph to track the performance of EVO stocks over time.

Evotec shares at a glance

Information last updated 2022-10-03.
Latest market close$9.00
52-week range$8.37 - $99.90
50-day moving average $11.74
200-day moving average $14.57
Wall St. target price$21.33
PE ratio 439.5
Dividend yield $0 (0%)
Earnings per share (TTM) $0.02

Buy Evotec shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Evotec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evotec price performance over time

Historical closes compared with the close of $9 from 2022-10-03

1 week (2022-09-27) 6.76%
1 month (2022-09-02) -16.12%
3 months (2022-07-05) -27.88%
6 months (2022-04-05) -41.79%
1 year (2021-10-04) -90.41%
2 years (2020-10-01) N/A
3 years (2019-10-02) 42.71
5 years (2017-10-04) 52.47

Is Evotec stock undervalued or overvalued?

Valuing Evotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Evotec's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Evotec's P/E ratio

Evotec's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 440x. In other words, Evotec shares trade at around 440x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Evotec's P/E ratio is best considered in relation to those of others within the drug manufacturers-specialty & generic industry or those of similar companies.

Evotec's EBITDA

Evotec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.2 million.

The EBITDA is a measure of a Evotec's overall financial performance and is widely used to measure a its profitability.

To put Evotec's EBITDA into context you can compare it against that of similar companies.

Evotec financials

Revenue TTM $683.6 million
Operating margin TTM 4.02%
Gross profit TTM $151.5 million
Return on assets TTM 0.88%
Return on equity TTM 0.15%
Profit margin 0.24%
Book value $3.61
Market capitalisation $3.1 billion

TTM: trailing 12 months

Evotec share dividends

We're not expecting Evotec to pay a dividend over the next 12 months.

You may also wish to consider:

Have Evotec's shares ever split?

Evotec's shares were split on a 4:1 basis on 20 October 2021. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Evotec shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Evotec shares which in turn could have impacted Evotec's share price.

Evotec share price volatility

Over the last 12 months, Evotec's shares have ranged in value from as little as $8.37 up to $99.9. A popular way to gauge a stock's volatility is its "beta".

EVO.US volatility(beta: 1.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evotec's is 1.1081. This would suggest that Evotec's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Evotec's beta into context you can compare it against those of similar companies.

Evotec overview

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc. ; CONBA Pharmaceutical Co. , Ltd. ; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co. , Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals.

Frequently asked questions

What percentage of Evotec is owned by institutions?
Currently 1.522% of Evotec shares are held by institutions.
How many people work for Evotec?
Latest data suggests 4,521 work at Evotec.
When does the fiscal year end for Evotec?
Evotec's fiscal year ends in December.
Where is Evotec based?
Evotec's address is: Essener Bogen 7, Hamburg, Germany, 22419
What is Evotec's ISIN number?
Evotec's international securities identification number is: US30050E1055

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site